Skip to content
Screener

Mesa Laboratories MLAB Sterilization And Disinfection Control — Cost Of Revenue Other

Similar metrics at other companies

STERIS logo
STEApplied Sterilization Technologies — Cost of Revenue
$140.1M+7.9%
Kadant logo
KAIFlow Control — Cost of revenue
$46.64M+8.0%
Xylem logo
XYLMeasurement and Control Solutions — Cost of Revenue
$309M-4.6%
TMH
TMHCCentral — Cost of Revenue
$217.1M-40.5%
FTE
FTEKAir Pollution Control — Cost Of Revenue
$989K+12.6%
KLA Corp. logo
KLACSemiconductor Process Control — Cost of revenue
$1.18B+18.7%

Other financials

Income statement

See full
Revenue$60.1M+1.0%
Gross profit$31.2M-0.5%
Operating income-$664.0K+85.5%
Net income$2.8M-40.3%
EPS (diluted)-$0.10+63.0%

Balance sheet

See full
Cash & equivalents$30.7M+44.3%
Total debt$78.5M-52.9%
Total equity$188.8M+9.4%
Total assets$419.2M-3.8%

Cash flow

See full
Operating cash flow$14.7M+678%
CapEx$559.0K-44.6%
Free cash flow$14.2M+1,504%

Valuation

See full
Market cap$574.42M+70.9%
Enterprise value$622.2M+28.9%
P/E42×
P/S2.3×+0.9×

Profitability

See full
Gross margin56.8%
Operating margin2.3%
Net margin1.5%+0.8pp
FCF margin21.2%+7.3pp

Returns & leverage

See full
Return on equity2.2%+1.1pp
Debt / equity0.4×-0.6×
Current ratio1.8×+1.1×

Where this comes from

Reported directly by Mesa Laboratories in its filing.

Tagged under the XBRL concept mlab:CostOfRevenueOther.

The source filing: Mesa Laboratories’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 5:17 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0001437749-26-026808
Three months ended June 30, 2026Sterilization and Disinfection ControlBiopharmaceutical DevelopmentCalibration SolutionsClinical GenomicsTotal
Less
Depreciation in cost of revenue43778111119745
Amortization in cost of revenue121379-191691
Other cost of revenue (b)6,7884,0205,1433,73919,690
Total segment cost of revenue7,3464,4775,2544,04921,126
Gross Profit (c)$17,159$7,582$8,031$6,240$39,012
Reconciling items:
Operating expense$31,981

Document

FAQ

What is Mesa Laboratories's sterilization and disinfection control — cost of revenue other?
Mesa Laboratories (MLAB) reported sterilization and disinfection control — cost of revenue other of $6.79M in Q2 2026.
How has Mesa Laboratories's sterilization and disinfection control — cost of revenue other changed year-over-year?
Mesa Laboratories's sterilization and disinfection control — cost of revenue other increased by 2.0% year-over-year, from $6.66M to $6.79M.
What is the long-term trend for Mesa Laboratories's sterilization and disinfection control — cost of revenue other?
Over 3 years (2023 to 2026), Mesa Laboratories's sterilization and disinfection control — cost of revenue other has grown at a 16.8% compound annual growth rate (CAGR), from $17.27M to $27.56M.
What does sterilization and disinfection control — cost of revenue other mean?
Includes miscellaneous direct costs associated with the production and delivery of products within the sterilization and disinfection control segment that are not categorized as depreciation or amortization. This provides visibility into the underlying operational overhead and variable costs of the segment's supply chain.

Ask your AI about Mesa Laboratories's sterilization and disinfection control — cost of revenue other.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude